Heidi Harvie MD, MSCE is an Associate Professor of Obstetrics and Gynecology at the Perelman School of Medicine and is the Director of Urogynecology & Pelvic Reconstructive Surgery at Pennsylvania Hospital.
Her research interests include health related quality of life measures and comparative effectiveness and cost-effectiveness, including conducting cost-effectiveness analysis within randomized controlled trials. She is the co-leader of the Identifying High-Value Health Care Working Group at LDI. She is the Principal Investigator and member of the Steering Committee for the NICHD sponsored Pelvic Floor Disorders Network (PFDN), a national network of seven research sites for conducting randomized clinical trials in pelvic floor disorders. She is chair of cost-effectiveness protocols for all clinical trials within the PFDN, including SUPeR (vaginal hysterectomy and uterosacral ligament suspension vs. mesh hysteropexy for uterovaginal prolapse), ASPIRe (sacral colpopexy, transvaginal mesh, and native tissue apical repair for vault prolapse), MUSA (midurethral sling vs. Botox for mixed urinary incontinence), TULIP (interventionist-guided pelvic floor muscle training vs. biofeedback device for improving urinary incontinence in postpartum women), and BASIS (transurethral bulking agent Injection vs. single-incision sling for stress urinary incontinence).
After graduating from the University of Pennsylvania School of Medicine and receiving her Master of Business Administration from The Wharton School, Dr. Harvie completed her residency in Obstetrics and Gynecology and fellowship in Female Pelvic Medicine and Reconstructive Surgery at the Hospital of the University of Pennsylvania. She received a Master of Science in Clinical Epidemiology at the University of Pennsylvania.